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INTRODUCTION
Natural killer (NK) cells were recognized as a separate lympho-
cyte lineage, with cytotoxicity and cytokine-producing effector
functions (1). NK cells comprise approximately 10% of all lympho-
cytes in human peripheral blood (2), and are important effector
cells in the innate immune system because they possess the unique
ability to directly lyse malignant- transformed, virus- infected cells
without prior sensitization and MHC class restriction (3). NK cell
cytotoxicity is mediated by the directed exocytosis of cytolytic
granules to release perforins and granzymes, which perforate the
target cell plasma cell membrane and trigger apoptosis, respec-
tively (4, 5). Furthermore, NK cells have been shown to play an
important role in immune responses by producing interferon
gamma (IFN-γ), the production of which by NK cells is known to
shape Th1 immune responses (6), activate APCs to further up-
regulate MHC class I and increase APC cytokine secretion (7),
activate the macrophage killing of obligate intracellular pathogens
(8), and have anti -proliferative effects on viral - and malignant-
transformed cells (9).
Although a large number of surface molecules on NK cells have
so far been identified as NK cell markers and receptors, sensitive
and truly specific pan-NK-cell markers have not yet been reported.
NK cells are currently defined phenotypically by their lack of ex-
pression of CD3 and expression of CD56, the 140-kDa isoform of
neural cell adhesion molecule (NCAM) found on NK cells and a
minority of T cells (10-12), i.e., CD3-CD56+ cells account for most
of the NK cell subset. CD56 was previously shown to be increased
upon the activation of NK cells (13), and it is one of the adhesion
molecules involved in the interaction between NK cells and target
cells (14). However, to the best of our knowledge, the relationship
between CD56 expression and NK cell activity has not yet been
elucidated in detail. Thus, we were interested in the utility of a func-
tional analysis of NK cells. In the present study, we examined the
relationship between NK cell -associated immunoreactivity and
the expression level of CD56 on human NK cells.
MATERIALS AND METHODS
Ethics Statement
The study was approved by the Ethics Committee for Human
Genome/Gene Research of the University of Tokushima and the
Ethics Committee for Kagawa Prefectural University of Health Sci-
ences. Written informed consent was obtained from all volunteers,
and all participants signed consent forms approved by the Ethics
Committee.
Study participants
Thirteen participants were enrolled from the Kagawa Prefec-
tural University of Health Sciences in this study (7 males and 6
females ; mean ageSD, 23.53.7 years). A flow cytometric analy-
sis of surface CD56 expression on NK cells was performed for all
participants. Cytotoxicity assay were performed for 10 participants
(6 males and 4 females ; mean ageSD, 22.01.2 years), while
an IFN-γ mRNA gene expression analysis was performed for 10
participants (6 males and 4 females ; mean ageSD, 24.14.1
years). Seven participants overlapped between measurement of
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cytotoxicity and IFN-γmRNA gene expression analysis.
PBMC isolation and Cell cultures
Human PBMCs were separated using a gradient centrifugation
method with Ficoll -Paque PLUS (GE Healthcare UK Ltd., Buck-
inghamshire, England) according to the manufacturer’s protocol.
PBMCs were washed two times with PBS, resuspended in RPMI
1640 medium (Thermo Fisher Scientific, Inc., MA, USA), supple-
mented with 10% heat- inactivated fetal bovine serum (Thermo
Fisher Scientific, Inc.), 2 mM L-glutamine, 100 U/mL penicillin,
and 100 μg/mL streptomycin (Thermo Fisher Scientific, Inc.), and
cultured at 37 in the humidified atmosphere of a 5% CO2 incu-
bator. A total of two million cells/mL PBMCs were stimulated with
rIL-2 or rIL-12 (1, 10, 100 U/mL ; BioLegend, Inc., CA, USA) for
18 h at 37, and were then washed two times with PBS before
further manipulation.
Flow cytometric analysis of surface CD56 expression on NK cells
In order to detect the expression of surface CD56 on NK cells,
PBMCs (1 million cells in 100 μL PBS) were incubated with an ap-
propriate volume of PerCP-conjugated anti -CD3-derived UCHT1
(BioLegend, Inc.) and PE-conjugated anti -CD56PE-derived C5.9
(Exalpha Biologicals, Inc. MA, USA) for 15 min at 4. Negative
controls were then used under the same conditions of each mouse
IgG isotype mAbs. PBMCs were washed two times with PBS, and
resuspended in 500 μL of 1 v/v % paraformaldehyde in PBS. PBMCs
were analyzed with Cell Lab Quanta SC (Beckman Coulter, Inc.,
CA, USA) flow cytometer equipped with a 488-nm laser air -cooled
configuration. As shown in Fig. 1, lymphocytes were first selected
in region 1 (R1) on an electric volume (EV) and side scatter (SS)
dot plot (Fig. 1A). Among the cells selected in gate R1, NK cells
were selected in a second region (R2) as CD3-CD56+ cells on an
FL-2 (CD56-PE)/FL-3 (CD3-PerCP) dot plot (Fig. 1B). NK cells
were defined as CD3-CD56+ cells, and the expression of CD56 on
these cells was quantified by geometric mean fluorescence inten-
sity (GMFI) (Fig. 1C). For each sample analyzed, a minimum of
20,000 events was acquired. All measurements were performed
under the same compensation settings.
Cytotoxicity assay
Cytotoxicity assay was performed using stimulated PBMCs as
effector cells. PBMCs were suspended at 1106 cells/mL in RPMI
1640 medium without phenol red. Raji cell line (JCRB Cell Bank,
Osaka, Japan) was used as the target cell. Raji cells were suspended
at 5104 cells/mL, and co-cultured with effector cells (50 μL/well
each) for 4h on a 96-well microplate at 37 with 5% CO2. The ef-
fector to target (E : T) cell ratio was 20 : 1. A colorimetric-based lac-
tate dehydrogenase (LDH) assay (Cytotoxicity Detection KitPLUS ;
F. Hoffmann-La Roche, Ltd., Basel, Switzerland) was used and
cytotoxic activity was calculated according to the manufacturer’s
instructions. Cell -mediated cytolysis were converted to percent
specific lysis (% SL) using the following formula : % SL=[(experi-
mental LDH release-spontaneous LDH release)/(maximum LDH
release-spontaneous LDH release)]100.
IFN-γ mRNA gene expression analysis
After stimulation with rIL-2 or rIL-12, NK cells were separated
from PBMCs using the EasySep Human NK Cell Enrichment Kit
(STEMCELL Technologies, British Columbia, Canada) to deter-
mine IFN-γ mRNA expression in NK cells. Total RNA was ex-
tracted using the QIAamp RNA Blood Mini Kit (Qiagen) from NK
cells according to the manufacturer’s protocol. cDNAs were ob-
tained from mRNA by reverse transcription (15 min at 42, 2 min
at 95) in a final volume of 20 μL, containing 1.0 ng of total RNA,
2.0 μL of 10PCR buffer, 5.0 mM MgCl2, 0.5 mM dNTP, 2.5 μM
Random hexamer primer, 1.0 U/μL RNase inhibitor, and 2.5 U/μL
MuLV Reverse Transcriptase (Thermo Fisher Scientific, Inc.).
The relative quantification of IFN-γ mRNA gene expression was
analyzed in hot-start qPCR using LightCycler FastStart DNA Mas-
ter SYBR Green I (Roche). In order to internally standardize gene
expression levels, we used a GAPDH housekeeping gene. Amplifi-
cations were performed with LightCycler 2.0 (Roche) in a final
volume 20 μL, containing 5.0 μL of cDNA, 2.0 μL of 10Master
Mix, 3.0 mMMgCl2, and 1.0 μM of each primer. PCR amplification
conditions were an initial denaturation step at 95 for 10 min,
followed by 45 cycles of denaturation at 95 for 10 sec, annealing
at 62 to 58 (Δ0.5/cycle) for 10 sec, and extension at 72 for
16 sec, followed by a quick chill to 4. GAPDH-specific primers
were as follows : forward 5’ -GCACCGTCAAGGCTGAGAAC-3’ ;
reverse 5’ -TGGTGAAGACGCCAGTGGA-3’, and IFN-γ specific
primers were as follows : forward, 5’ -AAAAATAATGCAGAGCC-
AAATTG-3’ ; reverse, 5’ -TAGCTGCTGGCGACAGTTCA-3’. Each
reaction was performed in triplicate, and the relative expression of
IFN-γmRNA was obtained using the ΔCT method. Lower ΔCT
values indicated higher mRNA levels.
Statistical analysis
Results were expressed as the meanstandard deviation. In
order to compare the treatment group to a single control group,
we assessed significance with the Dunnett’s test, which is a multi-
ple comparison procedure. A Spearman’s rank correlation was
applied to determine the relationship between different study pa-
rameters. P values below 0.05 were considered significant. IBM
SPSS Statistics 22.0 software was used to perform statistical analy-
ses.
Fig. 1. Flow cytometric analysis of surface CD56 expression levels on NK cells. These Figures are from a single representative subject. Lympho-
cytes were selected in region 1 (R1) on an electric volume (EV) and side scatter (SS) dot plot (A). NK cells (R2) were defined as CD3-CD56+ cells
(B), and surface CD56 expression on these cells was quantified by geometric mean fluorescence intensity (GMFI) (C).
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RESULTS
Expression levels of surface CD56 on NK cells after an in vitro
stimulation
Flow cytometric analysis was performed for quantification of sur-
face CD56 expression on NK cells. GMFI indicated fluorescence
intensity of a population of cells. The expression levels of surface
CD56 on NK cells following a stimulation with rIL-2 or rIL-12 were
shown in Fig. 2. Surface CD56 expression was significantly in-
creased by rIL-2 (Fig. 2A) and rIL-12 (Fig. 2B).
Cytotoxic activity after an in vitro stimulation and relationship
between cytotoxic activity and expression of surface CD56
The cytotoxicity assay was performed using stimulated PBMCs
as effector cells. The cytotoxic activity was determined with a LDH
assay. The cytotoxic activity of PBMCs following a stimulation
with rIL-2 or rIL-12 were shown in Fig. 3. The cytotoxic activity
was significantly enhanced following the stimulations with rIL-2
(Fig. 3A) and rIL-12 (Fig. 3B).
Fig. 3C and 3D show the relationship between cytotoxic activity
and the expression of surface CD56 on NK cells following a stimu-
lation with rIL-2 or rIL-12. The expression of surface CD56 cor-
related with cytotoxic activity (Fig. 3C : stimulation with rIL-2 ;
r=0.667, p0.001, Fig. 3D : stimulation with rIL-12 ; r=0.832, p
0.001).
Expression levels of IFN-γ mRNA after an in vitro stimulation and
relationship between IFN-γ mRNA expression levels and expres-
sion of surface CD56
IFN-γmRNA expression was quantified by real - time PCR. In
order to internally standardize gene expression levels, we used a
GAPDH as housekeeping gene. The amount of IFN-γ mRNA ex-
pressed was depicted as ΔCT values. Lower ΔCT values indicated
higher mRNA levels.Fig. 4A and 4B show IFN-γmRNA expression
levels following a stimulation with rIL-2 or rIL-12. As shown in
Fig. 4, the ΔCT values of IFN-γ mRNA was significantly decreased
by the stimulations with rIL-2 (Fig. 4A) and rIL-12 (Fig. 4B), i.e.,
IFN-γmRNA expression levels were significantly increased after
the in vitro stimulation. A negative correlation was also observed be-
tween CD56 GMFI and IFN-γ mRNA ΔCT values (Fig. 4C : stimu-
lation by IL-2 ; r=-0.839, p0.001, Fig. 4D : stimulation by IL-12 ;
r=-0.813, p0.001). In other words, CD56 expression levels and
IFN-γmRNA expression levels were positively correlated.
DISCUSSION
NK cells are large granular lymphocytes that play a role in the
cellular recognition and killing of virus- infected and tumor cells,
and their activation is important in the immune system in vivo.
Previous clinical studies reported the close relationship between
NK cell activity and various diseases. Konjevic et al. showed that
breast cancer patients in all clinical stages of the disease had sig-
nificantly decreased NK cell activity, and this decrease was the
Fig. 2. Expression levels of surface CD56 on NK cells following a stimulation with rIL-2 or rIL-12. PBMCs were stimulated with rIL-2 or rIL-12.
CD56 GMFI was analyzed after the stimulation with rIL-2 (A) or rIL-12 (B), respectively. Results are expressed as the meanstandard deviation
of 10 subjects. Significant differences were assessed to compare the treatment group to a single control group (*p0.05, **p0.01 ; Dunnett’s test).
Fig. 3. Cytotoxic activity and its relationship to surface CD56 expres-
sion on NK cells. Cytotoxic activity was determined using PBMCs as ef-
fector cells. Cytotoxic activity was analyzed after a stimulation with rIL-2
(A) or rIL-12 (B). Scatter diagrams represent the relationship between
CD56 GMFI and cytotoxic activity after a stimulation with rIL-2 (C) or
rIL-12 (D). Results are expressed as the meanstandard deviation of 10
subjects. Significant differences were assessed to compare the treatment
group to a single control group (**p0.01 ; Dunnett’s test).
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greatest in the advanced stage of the disease (15). Furthermore,
they revealed that the clinical stage of the disease also contributed
to the degree of NK cell dysfunction in non-Hodgkin’s lymphoma,
and NK cell activity was persistently decreased irrespective of the
histological type or clinical stage in Hodgkin’s lymphoma (16).
Furthermore, previous studies showed that the number of circu-
lating NK cells was reduced concomitant with a decrease in NK cell
cytotoxicity in several cases of autoimmune diseases (17-21). There-
fore, a detailed functional analysis of NK cells may lead to the de-
velopment of new therapies and diagnoses for various diseases.
Functional analyses of NK cell activation are currently evaluated
based on cytotoxicity and cytokine production.
NK cells express many different molecules on their cell surface
membrane. Of these, CD56 has been identified as the surface
marker that best characterize NK cells. CD56 is an important sur-
face marker for distinguishing NK cells (22), and has been reported
to increase following the activation of NK cells (13). However, to
the best of our knowledge, the relationship between CD56 expres-
sion and NK cell activity has not yet been elucidated in detail. Thus,
we were interested in the utility of a functional analysis on NK cells.
In the present study, we attempted to establish a human NK cell
activity evaluation method based on a quantitative flow cytometric
analysis of CD56 expression levels in NK cells.
In this study, we investigated changes in CD56 expression lev-
els, cytotoxic activity, and IFN-γ production with NK cell activity
as well as the relationships between cell membrane CD56 expres-
sion and cytotoxicity or IFN-γ production. The activation of NK
cells was stimulated by rIL-2 and rIL-12. IL-2 is known to pro-
mote NK cell proliferation, cytotoxicity, and cytokine secretion. In
humans, the lymph nodes, in which CD4+ T cells and NK cells
interact, may be the location at which T cell -derived IL-2 boosts
NK cells (23). In addition, the secretion of IL-12 by plasmacytoid
DCs was shown to increase NK cell proliferation, cytotoxicity, and
IFN-γ production (24). In the present study, we demonstrated
that the expression level of CD56 on NK cells, cytotoxic activity,
and IFN-γ production were significantly increased by the rIL-2
and rIL-12 stimulations and in a concentration-dependent manner
by the rIL-2 stimulation. Surface CD56 expression was also signifi-
cantly increased in case of using isolated NK cells from PBMCs
(data not shown). In addition, there was no significant change of
proportion between CD56dim and CD56bright subsets by a stimula-
tion, and we observed upregulation of CD56 expression in the
overall NK cells (data not shown). Furthermore, a positive corre-
lation was found between CD56 expression levels and cytotoxic
activity or IFN-γ mRNA expression. These results indicated that
the immune functions of activated NK cells were evaluable based
on the expression level of CD56 on NK cells. Measurement of
cytotoxic activity has widely been used to evaluate the immune
functions of NK cells, but this assay is complex. In this study, we
measured IFN-γ mRNA expression to evaluate capacity of IFN-γ
production because IFN-γ products in cell culture supernatant in-
dicated accumulated amount during stimulation.
A flow cytometric analysis for the quantification of CD56 expres-
sion can be performed easily and quickly. Recently, C-type lectin-
like cell receptors (CD69), the killer cell lectin- like receptor G1
(KLRG1), and the lysosomal-associated membrane protein-1
(LAMP-1 or CD107a) have been reported as markers of activated
NK cells. However, these cell surface markers are not expressed
on resting NK cells (25). In contrast, CD56 is expressed not only
on activated NK cells, but also on resting NK cells. Comparison
between surface CD56 expression and CD107a expression on ac-
tivated NK cells have still to be investigated. We suggest that sur-
face CD56 expression on NK cells is useful for evaluating NK cell
functions.
CONCLUSION
The quantification of CD56 expression levels is applicable to the
evaluation of cytotoxic activity and IFN-γ production in activated
NK cells. The measurement of CD56 expression represents an
easy and rapidly reproducible technique to evaluate the activated
state of NK cells and monitor NK cell activity in immunotherapy.
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